0%
Academic Webinar Series I organized by Liquid Biopsy Research Alliance (LIBRA) focusing on precision oncology diagnostics.
Liquid Biopsy: Redefining Precision Cancer Care is an Academic Webinar Series I organized by Liquid Biopsy Research Alliance (LIBRA), Mumbai, in association with Datar Cancer Genetics and Sir H. N. Reliance Foundation Hospital. Keynote speakers include Dr. Massimo Cristofanilli (Weill Cornell Medicine, New York), Dr. Sewanti Limaye (LIBRA), Dr. Prashant Kumar (LIBRA), Prof. Dr. Sandip Patel (UC San Diego), Prof. Dr. Kumar Prabhash, and Prof. Dr. Govind Babu. Discussions focus on early detection, liquid biopsy integration into routine clinical practice, and lung cancer awareness.
The primary aim of Liquid Biopsy: Redefining Precision Cancer Care (Academic Webinar Series I) is to deliver updated, evidence-based scientific insights into lung cancer management, molecular diagnostic algorithms, and novel targeted & immunotherapy regimens in NSCLC & SCLC. The program seeks to foster multidisciplinary collaboration among clinical specialists, enhance diagnostic accuracy, and translate groundbreaking clinical trial data into daily clinical practice.
The program was conducted as a structured virtual webinar & interactive online forum. The scientific agenda comprised keynote lectures by distinguished domain experts, case-based panel discussions on complex clinical scenarios, interactive Q&A sessions, and comprehensive reviews of landmark clinical trials in Thoracic Oncology.
The conference successfully equipped participating healthcare professionals with practical strategies for optimizing clinical decision-making in Thoracic Oncology. By establishing updated treatment algorithms and promoting collaborative care networks, the event reinforces commitment to improving patient survival rates and quality of life.